Protagonist Therapeutics, Inc (PTGX) insider trading

Over the last 12 months, 0 insiders bought $0 and 7 insiders sold $87.7M of Protagonist Therapeutics, Inc stock on the open market, according to SEC Form 4 filings.

Latest insider buys and sells

Which funds own Protagonist Therapeutics, Inc